Best AI Medical Diagnostic Platforms - Page 6

How Many AI Medical Diagnostic Platforms Products Does G2 Track?

Total Products under this Category: 118

Category Stats (Nov 2026)

  • Average Rating: 4.4/5 (↓0.23 vs Oct 2026) The average rating of products in this category, based on all submitted ratings
  • Top Trending Product: myExam Companion (+8.75%) - Among all products in this category, myExam Companion recorded the largest rating increase compared to last month

Last updated: November 13, 2026

How Does G2 Rank AI Medical Diagnostic Platforms Products?

Why You Can Trust G2's Software Rankings:

  • 30 Analysts and Data Experts
  • 300+ Authentic Reviews
  • 118+ Products
  • Unbiased Rankings

G2's software rankings are built on verified user reviews, rigorous moderation, and a consistent research methodology maintained by a team of analysts and data experts. Each product is measured using the same transparent criteria, with no paid placement or vendor influence. While reviews reflect real user experiences, which can be subjective, they offer valuable insight into how software performs in the hands of professionals. Together, these inputs power the G2 Score, a standardized way to compare tools within every category.

G2 Grid® for AI Medical Diagnostic Platforms

G2 Grid® for AI Medical Diagnostic Platforms plotting products by satisfaction and market presence

Highlighted products: OpenEvidence, PathAI, Viz.ai One, MR SmartSpeed, 5C Network, Deep Resolve, Qure AI, and Lunit.

Underlying data: [Grid® JSON](https://www.g2.com/categories/ai-medical-diagnostic-platforms/grids.json?focus%5B%5D=openevidence&focus%5B%5D=pathai&focus%5B%5D=viz-ai-one&focus%5B%5D=mr-smartspeed&focus%5B%5D=5c-network&focus%5B%5D=deep-resolve&focus%5B%5D=qure-ai-2022-07-05&focus%5B%5D=lunit)

Medtronic

Medtronic is a healthcare technology company that designs and develops AI-based products and solutions for the medical industry.

Who Is the Company Behind Medtronic?

  • Seller: Medtronic
  • HQ Location: Minneapolis, Minnesota, United States
  • LinkedIn® Page: www.linkedin.com
    100,679 employees on LinkedIn®

Medwise AI

Medwise AI is an advanced clinical search platform designed to assist healthcare professionals in quickly accessing accurate, evidence-based medical information at the point of care. By leveraging artificial intelligence and natural language processing, Medwise AI streamlines the retrieval of relevant clinical guidelines, research, and local protocols, enabling clinicians to make informed decisions efficiently. This tool is trusted by thousands of clinicians across over 1,000 NHS organizations, reflecting its reliability and effectiveness in the medical community. Key Features and Functionality: - Instant Clinical Answers: Medwise AI provides concise, evidence-based responses to clinical queries within seconds, significantly reducing the time spent searching for information. - Trusted Sources: The platform aggregates information from reputable sources, including NICE guidelines and other professional medical societies, ensuring the reliability of the content provided. - Customizable Content: Healthcare organizations can tailor Medwise AI to include local guidelines and protocols, making the tool adaptable to specific institutional needs. - User-Friendly Interface: Designed with clinicians in mind, the platform offers an intuitive interface that simplifies the search process, allowing users to focus more on patient care. Primary Value and Problem Solved: Medwise AI addresses the challenge of information overload and time constraints faced by healthcare professionals. With the rapid expansion of medical knowledge and frequent updates to clinical guidelines, clinicians often struggle to stay current. Medwise AI mitigates this issue by providing a centralized, efficient means of accessing up-to-date, evidence-based information, thereby enhancing decision-making, reducing unwarranted variations in care, and ultimately improving patient outcomes.

Who Is the Company Behind Medwise AI?

MESI Medical

MESI Medical is a developer of digital diagnostic solutions, dedicated to simplifying diagnostics and enhancing patient care. Their flagship product, the MESI mTABLET, is an innovative, modular diagnostic system designed to integrate various medical measurements into a single, user-friendly platform. This wireless system combines diagnostic tools, patient data management, and decision-making support, all seamlessly connected to electronic health records (EHRs). Key Features and Functionality: - All-in-One Wireless Diagnostics: The MESI mTABLET supports multiple diagnostic measurements, including Ankle-Brachial Index (ABI), Toe-Brachial Index (TBI), 12-lead ECG, spirometry, pulse oximetry, blood pressure, and vital signs. Users can add modules and applications as needed, ensuring flexibility and scalability. - Diagnostic Workflow Optimization: Standardized protocols and guided workflows streamline the diagnostic process, saving time, reducing errors, and ensuring consistent results. - Decision-Making Support: The system provides real-time data, trend visualizations, and clear measurement displays directly on the device, aiding clinicians in making informed decisions at the point of care. - Seamless EHR Connectivity: Integration with existing EHR systems eliminates manual data entry, reducing errors and enhancing workflow efficiency. - Flexible Setup Options: Designed for use in various healthcare settings, including clinics, hospitals, and home visits, the MESI mTABLET adapts to different environments without disrupting existing routines. Primary Value and User Solutions: The MESI mTABLET addresses the challenges of fragmented diagnostic tools and manual data entry by offering a comprehensive, connected solution. Healthcare professionals benefit from improved operational efficiency, reduced administrative workload, and enhanced diagnostic accuracy. Patients experience shorter appointments, faster results, and more proactive management of chronic conditions. By bringing diagnostics into the digital age, MESI Medical empowers healthcare providers to deliver better, faster care, ultimately improving patient outcomes.

Who Is the Company Behind MESI Medical?

AI can help you find the answers. G2 helps you trust them.

Connect G2 to Claude or ChatGPT for answers grounded in G2's trusted reviews, comparisons, and pricing from real user insights.

How it works

Method AI

Method AI is developing an AI-backed surgical navigation platform.

Who Is the Company Behind Method AI?

Milvue

Who Is the Company Behind Milvue?

  • Seller: Milvue
  • Year Founded: 2018
  • HQ Location: Paris, FR
  • LinkedIn® Page: www.linkedin.com
    29 employees on LinkedIn®

MindAffect

MindAffect specializes in developing advanced brain-computer interface (BCI) and artificial intelligence (AI) technologies to revolutionize hearing and vision diagnostics. Their patented systems interpret brain responses to auditory and visual stimuli, enabling rapid, accurate, and objective assessments across diverse patient groups, including children, the elderly, and individuals with disabilities.

Who Is the Company Behind MindAffect?

Mindpeak Breast H&E

Mindpeak Breast H&E is an advanced AI-powered software designed to assist pathologists in the primary analysis of breast cancer. It accurately detects invasive carcinoma and ductal carcinoma in situ (DCIS) in H&E-stained tissue samples, highlighting clinically relevant areas to support precise and informed diagnostic decisions. This tool streamlines the diagnostic process by automatically identifying malignant regions, thereby enhancing efficiency and reducing manual workload.

Who Is the Company Behind Mindpeak Breast H&E?

  • Seller: Mindpeak
  • Year Founded: 2018
  • HQ Location: Hamburg, DE
  • LinkedIn® Page: www.linkedin.com
    35 employees on LinkedIn®

Mindpeak Breast Metastasis Detection

Mindpeak Breast Metastasis Detection is an advanced AI-powered solution designed to assist pathologists in the efficient and accurate identification of breast cancer metastases within H&E stained lymph node tissues. By automating the detection process, this tool aims to reduce the time and effort traditionally required for manual analysis, thereby enhancing diagnostic efficiency.

Who Is the Company Behind Mindpeak Breast Metastasis Detection?

  • Seller: Mindpeak
  • Year Founded: 2018
  • HQ Location: Hamburg, DE
  • LinkedIn® Page: www.linkedin.com
    35 employees on LinkedIn®

Mindpeak Gastric PD-L1

Mindpeak Gastric PD-L1 is an advanced software solution designed for the automated analysis of gastric cancer tissue samples. Tailored for digital histopathology, it streamlines the evaluation of PD-L1 stained images by detecting and classifying tumor and immune cells, thereby enhancing the efficiency and accuracy of PD-L1 assessment in gastric cancer diagnostics.

Who Is the Company Behind Mindpeak Gastric PD-L1?

  • Seller: Mindpeak
  • Year Founded: 2018
  • HQ Location: Hamburg, DE
  • LinkedIn® Page: www.linkedin.com
    35 employees on LinkedIn®

Mindpeak Lung (NSCLC) PD-L1

Mindpeak Lung (NSCLC) PD-L1 is an advanced AI-powered software designed to automate the analysis of digital histopathology images of non-small cell lung cancer (NSCLC) tissue samples. This stand-alone module detects invasive carcinoma regions and accurately classifies tumor cells as PD-L1 positive or negative, providing a tumor proportion score (TPS) to assist pathologists in evaluating PD-L1 expression levels.

Who Is the Company Behind Mindpeak Lung (NSCLC) PD-L1?

  • Seller: Mindpeak
  • Year Founded: 2018
  • HQ Location: Hamburg, DE
  • LinkedIn® Page: www.linkedin.com
    35 employees on LinkedIn®

Mindpeak Onychomycosis AI

Mindpeak Onychomycosis AI is the first commercially available dermatopathology AI solution designed to detect nail fungus hyphae in whole-slide images without manual fine-tuning. It categorizes cases based on detection status, offering reliability comparable to human experts. The software supports most scanners and microscope cameras and can be seamlessly integrated into existing systems.

Who Is the Company Behind Mindpeak Onychomycosis AI?

  • Seller: Mindpeak
  • Year Founded: 2018
  • HQ Location: Hamburg, DE
  • LinkedIn® Page: www.linkedin.com
    35 employees on LinkedIn®

Model Medicines

Model Medicines uses human expertise and AI to accelerate the development of life-changing drugs at scale.

Who Is the Company Behind Model Medicines?

Moichor

Moichor is an innovative veterinary diagnostics company that leverages artificial intelligence to provide rapid, accurate, and cost-effective diagnostic solutions for a wide range of animal species. Their flagship product, Pathview, is an AI-assisted hematology and cytology system designed for in-clinic use, delivering preliminary diagnostic results in as little as 15 minutes. Key Features and Functionality: - AI-Assisted Diagnostics: Pathview offers pathologist-level diagnostic results directly within veterinary clinics, utilizing advanced AI technology. - Rapid Result Delivery: Provides preliminary diagnostic results in as little as 15 minutes, enabling swift clinical decision-making. - Broad Species Support: Capable of performing complete blood counts (CBC) and cytology evaluations for all animal species, including exotic animals. - Early Disease Detection: Facilitates early detection of diseases, contributing to improved patient outcomes and survival rates. - Cost Reduction: Reduces operational costs by an average of 35% by eliminating the need for external lab testing. - Increased Patient Capacity: Enhances clinic efficiency, allowing veterinarians to see and treat more patients by streamlining the diagnostic process. Primary Value and Problem Solved: Moichor addresses the need for faster, more accurate, and affordable diagnostic services in veterinary medicine. By integrating AI technology with in-clinic diagnostic capabilities, Moichor empowers veterinarians to make timely and informed decisions, leading to better patient care and outcomes. The Pathview system not only improves diagnostic accuracy but also enhances clinic efficiency and profitability by reducing reliance on external laboratories and associated costs.

Who Is the Company Behind Moichor?

  • Seller: Moichor
  • Year Founded: 2017
  • HQ Location: San Fransisco, US
  • LinkedIn® Page: www.linkedin.com
    2,335 employees on LinkedIn®

MSK X-Ray Reporting

qMSK is an AI-powered assistant designed to enhance the interpretation and reporting of musculoskeletal (MSK) X-rays, particularly in trauma cases. It analyzes radiographs across 15 anatomical regions—including the clavicle, ribs, shoulder, humerus, elbow, forearm, wrist, hand/fingers, hip, pelvis, femur, knee, tibia-fibula, ankle, and foot/toe—to detect signs of fractures. The system processes scans in under 20 seconds, providing outputs such as bounding boxes highlighting suspected fracture sites and summaries of AI findings.

Average Rating: 4.5/5.0

Total Reviews: 1

Who Is the Company Behind MSK X-Ray Reporting?

  • Seller: Qure.ai
  • Year Founded: 2016
  • HQ Location: New York , US
  • LinkedIn® Page: www.linkedin.com
    426 employees on LinkedIn®

Who Uses This Product?

  • Company Size: 100% Large

What Are Recent G2 Reviews of MSK X-Ray Reporting?

Nest Genomics

Nest Genomics is an AI-native platform designed to seamlessly integrate genomic information into clinical workflows, enabling healthcare organizations to identify, test, and manage patients at scale. By automating end-to-end care delivery, Nest facilitates the incorporation of precision medicine into routine practice, ensuring timely access to genetic information and personalized patient care. Key Features and Functionality: - Flexible Clinical Workflows: Nest adapts to existing genetic services workflows, allowing for full automation or selective use of specific capabilities. - Lab-Agnostic Platform: The platform supports integrated ordering from any laboratory, providing a standardized experience for both patients and providers. - Program Analytics & Insights: Real-time data enables measurement of program performance, workflow optimization, and tracking of clinical and economic outcomes. - Patient Identification: Utilizing AI-powered algorithms, Nest identifies patients meeting genetic testing criteria through Electronic Medical Records (EMR) and patient-reported data. - Clinical Decision Support: The platform offers integrated decision support tools to assist providers in managing patients with genetic results. - Longitudinal Management: Nest supports ongoing patient management, ensuring adherence to the latest clinical guidelines over time. Primary Value and Problem Solved: Nest Genomics addresses the challenges of integrating genomic information into clinical practice by providing a comprehensive, lab-agnostic solution that fits seamlessly into existing workflows. By automating patient identification, test ordering, and result management, Nest reduces operational burdens and enhances access to genetic services. This integration empowers healthcare providers to deliver personalized care efficiently, ultimately improving patient outcomes and advancing the adoption of precision medicine.

Who Is the Company Behind Nest Genomics?

Emma Stein
ES
Researched and written by Emma Stein
Updated October 21, 2026